Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical Chemistry.ORCID iD: 0000-0002-4137-5517
Uppsala University, Disciplinary Domain of Science and Technology, Chemistry, Department of Chemistry - BMC, Analytical Chemistry.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical Chemistry.
KTH Royal Inst Technol, Dept Prot Sci, Div Affin Prote, SciLifeLab, Stockholm, Sweden.
Show others and affiliations
2019 (English)In: Journal of Alzheimer's Disease, ISSN 1387-2877, E-ISSN 1875-8908, Vol. 67, no 2, p. 639-651Article in journal (Refereed) Published
Abstract [en]

Background: Alzheimer’s disease (AD) is diagnosed based on a clinical evaluation as well as analyses of classical biomarkers: Aβ42, total tau (t-tau), and phosphorylated tau (p-tau) in cerebrospinal fluid (CSF). Although the sensitivities and specificities of the classical biomarkers are fairly good for detection of AD, there is still a need to develop novel biochemical markers for early detection of AD.

Objective: We explored if integration of novel proteins with classical biomarkers in CSF can better discriminate AD from non-AD subjects.

Methods: We applied ELISA, mass spectrometry, and multivariate modeling to investigate classical biomarkers and the CSF proteome in subjects (n = 206) with 76 AD patients, 74 mild cognitive impairment (MCI) patients, 11 frontotemporal dementia (FTD) patients, and 45 non-dementia controls. The MCI patients were followed for 4–9 years and 21 of these converted to AD, whereas 53 remained stable.

Results: By combining classical CSF biomarkers with twelve novel markers, the area of the ROC curves (AUROCS) of distinguishing AD and MCI/AD converters from non-AD were 93% and 96%, respectively. The FTDs and non-dementia controls were identified versus all other groups with AUROCS of 96% and 87%, respectively.

Conclusions: Integration of new and classical CSF biomarkers in a model-based approach can improve the identification of AD, FTD, and non-dementia control subjects.

Place, publisher, year, edition, pages
IOS PRESS , 2019. Vol. 67, no 2, p. 639-651
Keywords [en]
Alzheimer's disease, cerebrospinal fluid, ELISA, mass spectrometry, mild cognitive impairment, proteomics
National Category
Neurology Geriatrics
Identifiers
URN: urn:nbn:se:uu:diva-377711DOI: 10.3233/JAD-180855ISI: 000457779300016PubMedID: 30614806OAI: oai:DiVA.org:uu-377711DiVA, id: diva2:1294682
Funder
VINNOVAGun och Bertil Stohnes StiftelseÅke Wiberg FoundationStiftelsen Gamla TjänarinnorAvailable from: 2019-03-08 Created: 2019-03-08 Last updated: 2019-04-29Bibliographically approved

Open Access in DiVA

fulltext(704 kB)421 downloads
File information
File name FULLTEXT01.pdfFile size 704 kBChecksum SHA-512
df3e17f04fcefc627b39cfcdbbfab62354f84fc4e69e2a6a90e375aa1ff61e9b00f79b8fc974f36f25eac9f5880d3cc570d262b2c7284a875ee0c55ef1282d39
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records

Emami Khoonsari, PayamShevchenko, GannaHerman, StephanieGiedraitis, VilmantasBrundin, RoseMarieDegerman Gunnarsson, MalinKilander, LenaLannfelt, LarsIngelsson, MartinKultima, Kim

Search in DiVA

By author/editor
Emami Khoonsari, PayamShevchenko, GannaHerman, StephanieGiedraitis, VilmantasBrundin, RoseMarieDegerman Gunnarsson, MalinKilander, LenaNilsson, PeterLannfelt, LarsIngelsson, MartinKultima, Kim
By organisation
Clinical ChemistryAnalytical ChemistryGeriatrics
In the same journal
Journal of Alzheimer's Disease
NeurologyGeriatrics

Search outside of DiVA

GoogleGoogle Scholar
Total: 421 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 476 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf